Innovation

 Breathe easy: improving
at-home asthma management

Cambridge-based Aseptika subsidiary Activ8rlives has created an app to help paediatric patients to better manage their asthma outside of hospital. What are the current challenges in at-home management of asthma for children, and how could this device transform patients’ lives? Chloe Kent reports. 

C

hildren with asthma often struggle to manage their condition. Factors like poor medication adherence, a lack of symptom awareness and substandard education about their condition can all conspire to cause repeat attacks. This not only leads to multiple hospital admissions, which can be stressful and difficult for patients and their families, but ultimately leaves children’s lives at risk.

Once an emergency has passed and a child’s asthma has been brought under control, patients are often referred to their general practitioner for future management of the condition. However, families can be reluctant to leave the highly supportive care offered by paediatric specialists and often continue on as hospital outpatients. This can lead to children facing a long series of disruptive medical appointments, repeatedly pulling them out of school and leisure activities.

The NHS’s long-term plan recognises that this is a problem throughout the healthcare system and has set a target of reducing the number of outpatient appointments by 30%.

Now Activ8rlives, a brand of Cambridge-based lung self-monitoring developer Aseptika, has come up with a solution for this problem.

Moderate-to-severe management

Asthma+me is a medically-certified app designed to help children manage the symptoms of moderate-to-severe asthma. It is intended to be used with patients who are being treated in outpatient clinics for repeat attacks, aged six to 12.

In outpatient clinics, once a child’s asthma is controlled, their parents are taught how to manage attacks. This involves learning what to do in the event of an asthma attack, the importance of following care plans for their child, and how to detect when their child is at risk of an attack. They also need to make sure their child takes their preventer inhaler, which helps make the airways less sensitive and make an asthma attack less likely.

When your child has just recovered from their first asthma attack and has had a hospital stay, it is daunting and overwhelming.

“There is already a wealth of educational material available for parents of children with asthma,” says Activ8rlives managing director Kevin Auton. “But when your child has just recovered from their first asthma attack and has had a hospital stay, it is daunting and overwhelming. There is so much to learn.”

This is where Asthma+me comes in. Using Activ8rlives’ PUFFClicker Bluetooth device, parents can check that the right number of doses have been taken, and when. PUFFClicker works with pressurised metred-dose inhalers, counting doses, whether or not the inhaler has been shaken properly before use and has a timer to support improved inhaler technique.

Making asthma data accessible

All of this data is uploaded to the Asthma+me app. The app also contains information on how the child’s lungs are doing using an electronic peak flow meter, which measures how fast air can be expelled, as well as data on pollution, weather and temperature alerts.

This is all compiled into a report for parents, which can be sent to a paediatric centre for review during a clinic appointment.

Clinicians have a much deeper understanding of exactly what affects their patient on a day-to-day basis.

Sheffield Hallam University consultant in paediatric respiratory and sleep medicine professor Heather Elphick, who works with Activ8rlives on the app, says: “It means clinicians have a much deeper understanding of exactly what affects their patient on a day-to-day basis, so they can make more accurate clinical decisions.”

The app is also accessible for children – it has a syllabus of 56 asthma management quizzes and short lessons built-in, which are presented through colourful illustrations and movies to engage young users.

Auton says: “In the future, it is hoped that by spending two to five minutes a day on these simple tasks, the need to have so many appointments will be reduced, and the child can spend more time at school and not have any more unscheduled visits to the hospital emergency room.”

Incorporating artificial intelligence

Moving forward, asthma attacks can be predicted by reviewing the key trends in data and reports generated by Asthma+me.

Auton says: “If the child has stopped taking their preventer inhaler, the use of their reliever inhaler has increased, their lung-function is decreasing, there are risks from environmental triggers such as high levels of pollution nearby, these trends become very obvious on the charts the Asthma+me app generates, which the parent can see.”

In a future version of the app, dubbed Asthma+me Smart, Activ8rlives wants to automate these alerts using artificial intelligence (AI). At the moment, the child’s clinician and parents are ultimately responsible for reviewing the information and seeing whether there’s any change in the treatment they’ve been taking, or their risk factors for attacks.

There are an estimated 1.1 million children in the UK with asthma.

Elphick says: “We’re working on the exact detail of the AI at the moment, but we anticipate that there’ll be an automated notification either to contact somebody, make a change to the child’s medication, or just to watch them closely and recap a lesson or video on the app.”

There are an estimated 1.1 million children in the UK with asthma, 110,000 of whom struggle to manage their condition and need to be treated at specialist clinics. Asthma+me recently won Best Patient-Focused Technological Development in the 2019 CARE Awards. At a time when the UK has some of the highest asthma rates in Europe, this couldn’t be more vital.

“By making parents and their children expert, by providing the tools for self-management, education and training, the cycle of repeated visits to outpatient clinics can be broken,” Auton says. “Education, engagement and empowerment lead to lower use of NHS services for the families of children with moderate-to-severe and difficult asthma.”

Share this article

Go to article: Home | Deep Space DiagnosticsGo to article: In this issueGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: Contents Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: NewsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Omnitron Go to article: The Medical Industry Briefing Go to article: Sab BroeckskesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Exceeding expectations: home sperm testing in the fertility tech marketGo to article: Siemens Company Insight Go to article: Siemens Go to article: Micro Systems TechnologiesGo to article: Space simulation: how gaming tech is being used to medically train astronautsGo to article: Braxton Manufacturing Go to article: CaelesteGo to article: Duodenoscopes: a dirty problemGo to article: Nelson Labs Company InsightGo to article: Nelson Labs Go to article: Mobile mind control: material engineering meets neurobiology Go to article: Abbott & CoGo to article: IMT Company InsightGo to article: IMTGo to article: Breathe easy: improving at-home asthma managementGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-GillGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Roundtable: debating the benefits of the NHS’s newly launched AI labGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: The long road to reliable organ printingGo to article: SartoriusGo to article: Cap BiomaterialsGo to article: URGENT/11 vulnerabilities showcase cybersecurity risks for connected medical devicesGo to article: Telemed Company InsightGo to article: TelemedGo to article: Admedus turns focus to TAVR market with next-generation tissue technologyGo to article: Turck Duotec Company Insight Go to article: Turck DuotecGo to article: 3BYGo to article: Medtronic’s extravascular ICD is pushing innovationGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Obstacle course for sperm is helping IVF scientists find the best swimmersGo to article: MicronovaGo to article: ARPA Company InsightGo to article: ARPAGo to article: Varian enters the embolisation particles marketGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Verdict Insights: The latest verdict insight from Medical Technology Go to article: TEN MedPrint Company Insight Go to article: TEN MedPrint Go to article: Future of healthcare: What will medicine look like in 2040?Go to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: 3D printing: Bringing assistive technology to the developing worldGo to article: iTAC Software Go to article: CarmoGo to article: Stepping up anatomical 3D printingGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article:  Coaxial Electrospinning: Revolutionising MedicineGo to article: SARA: The robot targeting European elderly careGo to article: ClippardGo to article: Bright PlasticsGo to article: Asahi InteccGo to article: Bias in the system: the leading healthcare algorithm with bias against black patientsGo to article: Mdeg Digital Go to article: Maraca InternationalGo to article: OptelGo to article: Body cameras: The benefits in mental healthcareGo to article: CleanControlling MedicalGo to article: Abatek InternationalGo to article: XavitechGo to article: Take a seat: The mental health chatbots encroaching on the therapist’s couchGo to article: mdi ConsultantsGo to article: MK FluidicsGo to article: AI for sight: The technology transforming infant eye disorder diagnosisGo to article: ProByLas Go to article: ITV Denkendorf ProduktserviceGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Mi3 Medical IntelligenceGo to article: The key list powered by GlobalDataGo to article: AerogelexGo to article: EventsGo to article: PI CeramicGo to article: Next issueGo to article: Qmedics Company Insight Go to article: QmedicsGo to article: Tresky